Kyverna Therapeutics Inc.
(KYTX)
undefined
undefined%
At close: undefined
4.42
0.23%
After-hours Dec 13, 2024, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 |
Revenue | - | 7.03M | 5.66M |
Cost of Revenue | 1.71M | 1.05M | 586.00K |
Gross Profit | -1.71M | 5.97M | 5.07M |
Operating Income | -62.41M | -29.38M | -26.35M |
Interest Income | 2.28M | 565.00K | 1K |
Pretax Income | -60.37M | -28.89M | -26.35M |
Net Income | -60.37M | -28.89M | -26.35M |
Selling & General & Admin | 12.48M | 8.01M | 6.15M |
Research & Development | 49.92M | 28.40M | 25.85M |
Other Expenses | - | -9.00K | -2.00K |
Operating Expenses | 62.41M | 36.41M | 32.00M |
Interest Expense | 187.00K | 65.00K | 3.00K |
Selling & Marketing Expenses | - | - | - |
Cost & Expenses | 62.41M | 36.41M | 32.00M |
Income Tax | - | 56.00K | 1K |
Shares Outstanding (Basic) | 673.62M | 25.80M | 25.80M |
Shares Outstanding (Diluted) | 673.62M | 25.80M | 25.80M |
EPS (Basic) | -0.00 | -1.12 | -1.02 |
EPS (Diluted) | -0.00 | -1.12 | -1.02 |
EBITDA | -58.47M | -27.78M | -25.76M |
Depreciation & Amortization | 1.71M | 1.05M | 586.00K |